Wird geladen...
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to being based on subunit components. Since this diminishes immunogenicity, vaccine adjuvants that enhance the immune response to purified antigens are critically needed. Further advantages of adjuvants include dos...
Gespeichert in:
| Veröffentlicht in: | Pharmaceutics |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911620/ https://ncbi.nlm.nih.gov/pubmed/33499143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020142 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|